TG Therapeutics | Umsatzkosten



Cost Of Sales Veränderung Datum
AbbVie USD 4.4B 184M 2024-12
Alaunos Therapeutics 0 18K 2024-09
Amgen USD 3.11B 198M 2024-12
Ardelyx USD 18.26M 2.54M 2024-12
Bayer EUR 5.72B 633M 2024-12
Biogen USD 583.5M 55.2M 2024-12
Corcept Therapeutics USD 2.96M 89K 2024-12
Dynavax Technologies USD 13.41M 326K 2024-12
Gilead Sciences USD 1.58B 7M 2024-12
J&J USD 7.11B 151M 2024-12
Novartis USD 3.32B 90M 2024-12
PTC Therapeutics USD 16.28M 5.44M 2024-12
Regeneron Pharmaceuticals USD 565.4M 74.3M 2024-12
Roche Holding CHF 4.13B 393.5M 2024-12
TG Therapeutics USD 15.4M 6.06M 2024-12
Vertex Pharmaceuticals USD 423.4M 30.8M 2024-12



TG Therapeutics Umsatzkosten - Diese Werte, historische Daten, Prognosen, Statistiken, Diagramme und ökonomische Kalender - Apr 2025.